Thomas Mandrup‐Poulsen

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

Claus M. Larsen, Mirjam Faulenbach, Allan Vaag et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Medicine, Endocrinology, Pharmacology +17

A guiding map for inflammation

Mihai G. Netea, Frances R. Balkwill, Michel Chonchol et al. · Nature Immunology · 2017 · 823 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Cytotoxicity of Human <i>p</i> I 7 Interleukin-1 for Pancreatic Islets of Langerhans

Klaus Bendtzen, Thomas Mandrup‐Poulsen, Jørn Nerup et al. · Science · 1986 · 531 citations

Life Sciences, Endocrinology, Immunology +14

Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca2+, Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-Cells

Alessandra K. Cardozo, Fernanda Ortis, Joachim Størling et al. · Diabetes · 2005 · 518 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

Claus M. Larsen, Mirjam Faulenbach, Allan Vaag et al. · Diabetes Care · 2009 · 414 citations · Full text

Medicine, Endocrinology, Pharmacology +16